Nutrition Support in Catastrophic Injury Life Care Plans: What the Clinical Criteria Require

In catastrophic abdominal injury cases, few line items move a damages figure like nutrition support. Home parenteral nutrition — intravenous feeding delivered through a central catheter — runs somewhere in the range of $103,000 to $176,000 per year for an adult in the United States. Projected across a young plaintiff’s life expectancy, that single entry can account for the majority of a life care plan’s total value.

Yet nutrition support is among the least rigorously examined components of those plans. It is often projected from the patient’s status at a point when the clinical picture was, by the nature of the injury, at its worst. Counsel on both sides are frequently working without a clear sense of what the clinical criteria actually require.

This article sets out those criteria. It is not an argument that projections are typically too high or too low. It is an account of what determines the answer.

The question is not “is she on TPN now”

A patient who survives devastating abdominal trauma will very often require parenteral nutrition at some stage. Virtually all patients with short bowel syndrome need it in the period immediately following resection, and few are able to discontinue it before leaving the hospital.

That fact tells you very little about year five.

The clinically meaningful question is whether the patient is likely to achieve enteral autonomy — the ability to maintain nutrition and hydration by mouth or by feeding tube, without intravenous support. And that turns on two things: remnant anatomy, and where the patient sits on a recovery curve that unfolds over years.

Anatomy is the primary predictor

Short bowel syndrome is conventionally defined by fewer than 200 cm of remaining small intestine. But length alone is a crude measure. What actually predicts outcome is the combination of remnant length, whether the ileum was preserved, and whether colon remains connected in continuity.

The field recognizes three anatomic patterns, and the probability of long-term intravenous dependence differs markedly among them:

• End-jejunostomy or ileostomy — ileum, colon, and part of the jejunum resected, with a stoma. Dependence is variable but substantially higher below roughly 115 cm of remaining jejunum.
• Jejunocolic anastomosis — ileum and a portion of colon resected, remaining segments joined. Dependence is variable and generally higher below roughly 60 to 65 cm of jejunum.
• Jejunoileal anastomosis — ileocecal valve and entire colon present. Probability of long-term dependence is low except at very short remnant lengths.

Preserved colon matters more than most non-clinicians expect. The colon salvages energy by fermenting malabsorbed carbohydrate and is essential to water and electrolyte handling. A patient with colon in continuity is in a materially different prognostic category from one with an end stoma and the same small bowel length.

The documents that answer this are the operative reports. Surgeons frequently record an estimate of remnant bowel length in a single sentence. That sentence often does more prognostic work than any other page in the record. Triangulating those estimates with imaging and endoscopy reports is the work the experts.

Adaptation continues for years

Intestinal adaptation is a structural process, not a hopeful abstraction. After resection, the remaining small bowel hypertrophies and increases its absorptive capacity. Villous height increases, transit slows, and absorption improves measurably over months to years.

The consequence is that any assessment made in the months after injury systematically understates eventual function. More than half of adults with short bowel syndrome are weaned completely from parenteral nutrition within five years of diagnosis.

This is the single most important fact for evaluating a projection, and it cuts in a specific direction: a life care plan built on the patient’s condition at three or six or twelve months post-injury is not describing a steady state. It is describing a point on a curve.

The corresponding question for any projection is straightforward — what is the most recent clinical documentation, and what does the trajectory between the earliest and latest records show? Weight gain, resumption of oral intake, reduced infusion days, and declining output from a venting gastrostomy are all objective markers of a recovering trajectory.

Reversible contributors are common

When a patient is not progressing toward autonomy, the limiting factor is frequently something other than bowel length:

• Opioids produce profound dysmotility of both stomach and intestine. In a patient with multiple laparotomies and legitimate pain, chronic opioid use is easy to overlook as background — and is often the dominant obstacle.
• Cannabis is associated with a recognized hyperemesis syndrome, and long-term management requires complete cessation. It is rarely asked about directly.
• Unrestored bowel continuity denies the patient the absorptive contribution of the distal segment. Restoration, when it can be done safely, frequently converts a dependent patient to an autonomous one.
• Anastomotic stricture causing chronic partial obstruction presents as intermittent vomiting and distension, is easily mistaken for dysmotility, and is potentially surgically correctable.
• Unresolved intra-abdominal sepsis suppresses gut function until the source is controlled.

None of these makes a plan wrong. All of them are relevant to whether a projection of permanent support reflects an irreversible anatomic reality or a modifiable clinical situation.

Delayed gastric emptying after trauma

Gastroparesis following major abdominal surgery is common and usually multifactorial — opioid effect, inflammation, adhesions, sometimes vagal injury. Unlike the gastroparesis of long-standing diabetes, post-surgical gastroparesis tends to improve gradually over months to years.

Where it persists, effective treatment exists. Gastric per-oral endoscopic myotomy is an endoscopic, incision-free procedure with reported long-term clinical success in the range of 65% to 86% at three to four years. Promotility medication and gastric electrical stimulation are also available and often reduce symptoms.

The practical significance is that persistent gastroparesis is generally a treatable condition rather than a permanent one, and a plan projecting decades of nutrition support on the basis of delayed emptying should be read against that literature.

When permanent support is appropriate

It would be a serious error to read the above as suggesting that projections of long-term parenteral nutrition are generally unwarranted. They are sometimes exactly right.

Patients with very short remnant length, no remaining colon, an end jejunostomy, extensive loss of ileum, or established anatomic intestinal failure may legitimately require intravenous support for life. Some patients fail structured weaning despite optimal management. Some have complicating conditions — radiation injury, motility disorders, recurrent obstruction — that make autonomy unattainable. For these patients, permanent parenteral nutrition is not merely reasonable; it is life-sustaining, and a plan that omits it is inadequate.

The clinical criteria distinguish these situations from one another. That is the point of applying them. An expert who concludes that every projection is inflated is not applying criteria — they are applying a conclusion.

What to look for in the record

Regardless of which side you represent, the same items carry the weight:

1. Operative reports with a remnant bowel length estimate. Frequently the most informative documents.
2. Whether bowel continuity has been restored, and if not, whether restoration was contemplated, ruled out or still feasible.
3. The most recent clinical documentation, and the size of any gap since the last treating-physician note. A projection resting on records that are long stale is describing a patient who may no longer exist.
4. Trajectory markers — weight, oral intake, infusion days per week, gastrostomy output.
5. The current medication list, specifically opioids, and any documented substance use.
6. Whether a structured weaning protocol was ever attempted, and if it failed, on what basis.
7. Whether a registered dietitian and a surgeon are actively managing the plan. In practice, when specialist follow-up lapses, nutrition support often continues by default rather than by decision.

A note on the difference between plans and prognoses

A life care plan is a projection of future need. It is not a clinical prognosis, and the person preparing it is often not the person best positioned to assess the trajectory of intestinal recovery.

That is not a criticism of life care planners, whose work is genuinely difficult and who depend on the clinical information available to them. It is an observation about where the analysis needs clinical input: the nutrition and gastrointestinal components of a catastrophic plan require someone who can read the operative reports, apply the anatomic criteria, and situate the patient on a recovery curve.

Done properly, that analysis sometimes supports the projection as written. Sometimes it substantially revises it. Either outcome is more useful to a court than a number carried forward from the worst month of a patient’s life.

Dr. Kent Sasse, MD,MPH, FACS, FASCRS, FASMBS, is a Bariatric surgery thought leader. He has performed over 5,000 primary bariatric surgical procedures and 500 revisional bariatric procedures. He is the Founder and Medical Director of a nationally accredited bariatric surgery center and an award-winning teacher. Dr. Sasse is a widely published scientist and author of nine books as well as an inventor and patent holder of a bariatric surgical device. His clinical experience includes bariatric surgery and endoscopy, sleeve gastrectomy, gastric bypass, duodenal switch, reoperative surgery, revisional surgery, hiatal hernia, wound care, Barrett's esophagus, hernia mesh, hernia mesh explantation, endoscopic stenting, leaks, Ambulatory Surgery Centers, and solving complications.  Dr. Sasse is a prolific public speaker and he serves on the University of Nevada School of Medicine faculty. He is an experienced expert witness at both deposition and trial. Dr. Sasse can be contacted at 707.597.2999 or drsasse@sassesurgical.com.

©Copyright - All Rights Reserved

DO NOT REPRODUCE WITHOUT WRITTEN PERMISSION BY AUTHOR.